Anti-Clostridium difficile Toxin B antibody [EPR23357-19]

The University of Virginia awarded a purchase order (PO-0471471) to Epitomics Inc on August 20, 2026, for the supply of specialized laboratory reagents. The contract, valued at $569.25, calls for the delivery of one unit of Anti-Clostridium difficile Toxin B antibody [EPR23357-19] to Dr. Deiziane Viana Da Silva Costa. This antibody product is classified as a diagnostic or research reagent used in the identification and analysis of Clostridium difficile toxin B, a pathogenic bacterium commonly associated with healthcare-acquired infections.

As a Virginia-based procurement through the University of Virginia, this single-line-item purchase represents a routine acquisition of specialized laboratory materials. The contract establishes Epitomics Inc as the prime contractor responsible for fulfilling the antibody supply requirement. The modest contract value and unit-based delivery structure indicate this is a discrete procurement transaction for immediate or near-term research or diagnostic needs at the University of Virginia's facilities.